Exempt Offering Notice · D
Intelligent Bio Solutions Inc.
INBSNASDAQEQUITYCurrent
Exempt Offering Notice
Structured filing — D
primary_doc.xml
Issuer
- Name
- INTELLIGENT BIO SOLUTIONS INC.
- CIK
- 0001725430
- Entity type
- Corporation
- Jurisdiction
- DELAWARE
- Phone
- 646-790-5756
- Street
- 135 West 41st Street
- Street (continued)
- 5th Floor
- City
- New York
- State / country code
- NY
- State / country
- NEW YORK
- Postal code
- 10036
- Incorporated more than five years ago
- true
- Previous EDGAR names
- GBS Inc. · Glucose Biosensor Systems (Greater China) Holdings, Inc.
Related person 1
- First name
- Harry
- Last name
- Simeonidis
- Relationships
- Executive Officer
- Relationship clarification
- Chief Executive Officer
- Street
- 135 West 41st Street 5th Floor
- City
- New York
- State / country code
- NY
- State / country
- NEW YORK
- Postal code
- 10036
Related person 2
- First name
- Spiro
- Last name
- Sakiris
- Relationships
- Executive Officer
- Relationship clarification
- Chief Financial Officer
- Street
- 135 West 41st Street 5th Floor
- City
- New York
- State / country code
- NY
- State / country
- NEW YORK
- Postal code
- 10036
Related person 3
- First name
- Steven
- Last name
- Boyages
- Relationships
- Director
- Relationship clarification
- Director
- Street
- 135 West 41st Street 5th Floor
- City
- New York
- State / country code
- NY
- State / country
- NEW YORK
- Postal code
- 10036
Related person 4
- First name
- Jonathan
- Last name
- Hurd
- Relationships
- Director
- Relationship clarification
- Director
- Street
- 135 West 41st Street 5th Floor
- City
- New York
- State / country code
- NY
- State / country
- NEW YORK
- Postal code
- 10036
Related person 5
- First name
- Jason
- Last name
- Isenberg
- Relationships
- Director
- Relationship clarification
- Director
- Street
- 135 West 41st Street 5th Floor
- City
- New York
- State / country code
- NY
- State / country
- NEW YORK
- Postal code
- 10036
Related person 6
- First name
- Nicola
- Last name
- Fraser
- Relationships
- Director
- Relationship clarification
- Director
- Street
- 135 West 41st Street 5th Floor
- City
- New York
- State / country code
- NY
- State / country
- NEW YORK
- Postal code
- 10036
Offering
- Industry
- Other Health Care
- Revenue range
- Decline to Disclose
- Exemption codes
- 06b
- Amendment
- false
- First sale date
- 2026-08-31
- Offering lasts more than one year
- false
- Equity securities
- true
- Business combination
- false
- Business combination clarification
- [blank]
- Minimum investment accepted
- 0
- Total offering amount
- 4,979,631
- Amount sold
- 4,979,631
- Remaining amount
- 0
- Amount clarification
- Offering closed September 2, 2026
- Non-accredited investors reported
- false
- Investors already participating
- 1
Commissions, fees and proceeds
- Sales commissions
- 399,999
- Finders’ fees
- 0
- Commission / fee clarification
- Ladenburg received $399,999.83 in commission, a $49,999.98 management fee, $60,000 expense reimbursement, and warrants for 101,832 shares of common stock. Ladenburg also receives 9% commission on gross proceeds from Series N-1 and N-2 Warrant exercises.
- Gross proceeds used
- 0
- Use of proceeds clarification
- [blank]
Sales compensation recipient 1
- Name
- Ladenburg Thalmann & Co. Inc.
- CRD
- 505
- Associated broker-dealer
- None
- Broker-dealer CRD
- None
- Foreign solicitation
- false
- Street
- 640 5th Avenue
- Street (continued)
- 4th Floor
- City
- New York
- State / country code
- NY
- State / country
- NEW YORK
- Postal code
- 10019
- States of solicitation
- IL
- Solicitation description
- ILLINOIS
Signature authorization
- Authorized representative
- false
Signature 1
- Issuer
- INTELLIGENT BIO SOLUTIONS INC.
- Signer
- Spiro Sakiris
- Signed
- /s/ Spiro Sakiris
- Title
- Chief Financial Officer
- Date
- 2026-09-14
Company context
Bio Solutions Inc. Intelligent Bio Solutions Inc. (Nasdaq: INBS) is a medical technology company delivering intelligent, rapid, non-invasive testing solutions. The Company believes that its Intelligent Fingerprinting Drug Screening System will revolutionize portable testing through fingerprint sweat analysis, which has the potential for broader applications in additional fields. Designed as a hygienic and cost-effective system, the test screens for the recent use of drugs commonly found in the workplace, including opiates, cocaine, methamphetamine, and cannabis. With sample collection in seconds and results in under ten minutes, this technology would be a valuable tool for employers in safety-critical industries. The Company’s current customer segments outside the U.S. include construction, manufacturing and engineering, transport and logistics firms, mining, drug treatment organizations, and coroners.